Podcasts about cancer treatment

Solid tumors represent one of the largest and most challenging areas in cancer treatment. In this interview, GT Biopharma (NASDAQ: GTBP) CEO Michael Breen explains why the company is expanding its platform into solid tumors and how its NK engager technology is designed to activate the body's natural immune response.Breen discusses the science behind GTB-5550, why B7H3 is a compelling target across many solid tumors, and how preclinical results support the company's next steps. He also outlines key milestones from 2025 and what investors should watch as GT Biopharma moves toward clinical trials and data readouts in 2026.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://www.youtube.com/watch?v=I7-Vd8PO8L0And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

In this episode of Navigating Cancer TOGETHER, host Talaya Dendy welcomes back award-winning journalist, poet, and two-time cancer survivor Annamaria Scaccia. Annamaria shares her powerful story of surviving both kidney and thyroid cancer by age 40 and how she is transforming her life through bodybuilding and advocacy. They discuss the psychological power of strength training, the challenges of managing rare cancer types, how cancer impacts relationships, and the importance of self-awareness in the healing process. Tune in to discover how physical discipline, raw truth, and giving yourself grace can help you reclaim your power and navigate the complex emotional landscape of long-term survivorship.✨Episode Highlights:00:02:32 Annamaria's Origin Story00:05:39 Transitioning from Kickboxing to Bodybuilding after a Kidney Cancer Diagnosis00:09:18 Bodybuilding for Healing and Trauma Recovery00:17:45 Self-Awareness and the Truth of the Iron00:20:50 Navigating a Second Cancer Diagnosis00:27:41 Addressing Multiple Primary Cancers Transcript: https://bit.ly/podscript178Connect & Engage with Annamaria:Links: https://linktr.ee/gotchascaccia?utm_source=linktree_profile_share<sid=e18723c7-b1a1-4be2-9794-507317879f6cInstagram: https://www.instagram.com/gotchascaccia/LinkedIn: https://www.linkedin.com/in/annamariascaccia/Podcast: https://www.kidneycancer.org/podcast/National Cancer Survivor Month Episode: https://youtu.be/JlET8Ljujiw?si=f1_b4aAJ_rkTopk2Join the Community: Looking for a safe space to share your raw truth? Join the waitlist for the Navigating Cancer TOGETHER Cancer Community Forum. Connect with others in a private, supportive environment completely free from the noise and distractions of social media. Be the first to know when we open: https://www.ontheotherside.life/forum-waitlistSponsor: This episode is brought to you by On the Other Side. Thank you for your support! It helps to bring these critical conversations to life.Hosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted on Ausha. See ausha.co/privacy-policy for more information.

In Episode 22, we explore the importance of communication with individuals living with cancer. Lisa Sheeran, a Breast Cancer Clinical Nurse Consultant, and Maria Ftanou, the Director of the Psychosocial Oncology Unit at Peter MacCallum Cancer Centre in Melbourne, discuss "Oncology Unscripted: Guiding Patients through Cancer Treatment." They share best-practice examples for helping patients navigate their diagnosis whilst dealing with the complex and diverse emotions that arise during their diagnosis and treatment.

In this powerful episode of the Healing Pen and a Mic companion podcast, host Talaya Dendy sits down with Lisa Beckendorf, a celebrated cancer survivor and patient advocate.Lisa shares her personal journey through multiple cancer diagnoses and the pivotal moment she transitioned from a career in commercial real estate to full-time advocacy. Initially asking, "Why me?", she realized her experience was a powerful way to give back to the cancer community.This conversation dives into the transformative impact of journaling and storytelling in the healing process. Lisa highlights how the practice, central to the Healing Pen and a Mic Workshop offers emotional release, fosters deep community connections, and is a critical tool for personal growth.Whether you are navigating a diagnosis, supporting a loved one, or seeking to turn your personal story into powerful action, this episode offers invaluable insights on finding solace, strength, and purpose through writing and community.Support Our Mission / Partner With Us:Bring Healing to Your Community: Interested in hosting The Healing Pen and a Mic workshop in your city or organization? We'd love to partner with you!Sponsor Future Workshops: Help us continue offering these much-needed, workshops to the cancer community.For partnership or sponsorship inquiries, please email us at nctpodcastfan@gmail.com.

Michell Fullmer, RDN, LDN, CSP, CNSC Nutrition plays a powerful role in supporting children through cancer treatment, but it's not always easy for caregivers to know what's best, especially when there are taste changes, appetite shifts, and treatment side effects. In this episode, we sit down with Michell Fullmer, a registered dietitian at Nemours Children's Hospital, to share practical insights that simplify nutrition during cancer care, reduce mealtime stress, and empower caregivers to make choices that help their child feel better every day. Join us for myth-busting, actionable tips, and reassurance from an expert who has guided countless families through this important part of care. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Free Nutrition Consultations Nemours Children's Health Blood Cancer United Dare To Dream Project Navigating Cancer for Children and Teens HealthyWeight.gov Additional Blood Cancer United Support Resources: Information Specialists Free telephone/web patient programs Clinical Trial Support Center Advocacy and Public Policy Free booklets Financial support Young Adult Resources Support groups Survivorship Workbook Community Caregiver support Caregiver Workbook Mental Health Resources Supported by Nemours Children's Health. The post Nutrition Made Simple: Helping Kids Thrive During Cancer Treatment first appeared on The Bloodline with Blood Cancer United Podcast.

Scientific breakthroughs and technological innovation are transforming cancer care and improving outcomes for millions of patients and survivors. On Thursday, Dec. 4, join Washington Post Live for in-depth conversations about the progress made and the future of treatment and care.

On Talking Royals this week, Charlene White is joined by our Royal Editor Chris Ship, Royal Expert Lizzie Robinson, and social media Royal Commentator Amanda Matta. They discuss the King's rare and deeply personal message as part of this year's Stand Up To Cancer campaign - as he continues to recover from his own cancer diagnosis. In his biggest update yet, he revealed his treatment will continue - but it will be reduced in 2026.  He said: "Today I am able to share with you the good news that thanks to early diagnosis, effective intervention and adherence to ‘doctors' orders', my own schedule of cancer treatment can be reduced in the New Year," Charles said in his video message. "This milestone is both a personal blessing and a testimony to the remarkable advances that have been made in cancer care in recent years." Also on this week's Talking Royals: Prince Harry's security arrangements will be reassessed in a move that could pave the way for him to bring his family to the UK on future visits. Could Charles soon be seeing more of his grandchildren? A letter from Meghan to her estranged father Thomas Markle as he heals from a recent leg amputation. We look at rare footage of a baby Prince William taking his first steps in front of cameras, alongside Diana and Charles. And we go inside the Queen's visit to the set of one of her favourite shows - Rivals - based on the novel by her late, great friend, Dame Jilly Cooper.

AP correspondent Ed Donahue reports on a royal health update.

Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer prognosis and treatment prediction. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Craig Eagle, Chief Medical Officer of Guardant Health, a precision medicine company that offers blood tests to inform cancer treatment decisions. Eagle discusses Guardant's participation in the National Cancer Institute's Vanguard Study, as well as screening, recurrence monitoring, and therapy selection focused on conquering cancer with data, with examples especially in the colorectal cancer space. You can listen to episode 229 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Early cancer genomic panel testing aimed at detecting genetic changes in cancer cells significantly increases patients' chances of receiving effective therapies and reduces mortality risk, according to a study released recently by Kyoto University Hospital.

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Dr. Dale: When I run into a problem, the first thing I have to do is tell myself, don't be afraid. You've solved other problems in the past. You can solve this one.Millions of people worldwide face the devastating impact of cancer, with countless lives lost each year to tumors that no longer respond to existing treatments. Dr. Dale Walker, Co-founder and CEO of The Burlington HC Research Group (BHCRG), is working to change that narrative with her groundbreaking development of a new family of anti-cancer drugs. These drugs have the potential to revolutionize treatment for cancers that have become resistant to current therapies.“We tested our drugs against 15 human cancer cell lines, representative of seven different tissues, and the drug works against all of them,” Dale explained. In the U.S. alone, over 600,000 people die annually from cancer, often because their tumors no longer respond to treatment. Dale's research offers a glimmer of hope for patients and their families.Unlike traditional drug development that focuses on a single compound, Dale and her team have created a family of drugs—called BRG drugs—by combining two FDA-approved ingredients in a novel way. These drugs not only enhance the effectiveness of existing cancer treatments but also demonstrate the ability to kill nearly all cancer cells after a single dose in preclinical studies. “Most anti-cancer agents just slow tumor growth. Ours hit both marks—killing tumor cells at a safe dose level,” she said.With such promising results, Dale and her husband Vernon, who co-leads the research, are pushing forward. However, taking these drugs through the necessary safety and efficacy tests requires significant funding. To accelerate progress, BHCRG is raising capital through a regulated crowdfunding campaign on the FundingHope platform. Crowdfunding offers a faster alternative to traditional funding sources, enabling the Walkers to bypass lengthy government grant timelines.“Crowdfunding is a lifeline. We have family members and friends with cancer. We can't wait years,” Dale shared. For investors, the opportunity to back a potential game-changing cancer therapy is compelling, both for its societal impact and long-term financial potential.Dale's passion and perseverance shine through in her work. Her innovative approach to drug development could save countless lives. Supporting her mission on Funding Hope isn't just an investment in a company—it's an investment in hope.tl;dr:Dale Walker shares her innovative work on new anti-cancer drugs targeting resistant tumors.BHCRG's BRG drugs show promising preclinical results, killing almost all tumor cells with one dose.Dale explains crowdfunding's role in accelerating drug development for life-saving cancer treatments.She discusses perseverance as her superpower, solving challenges by embracing and examining problems.Today's episode highlights how crowdfunding enables investors to support impactful innovations in healthcare.How to Develop Perseverance in Problem-Solving As a SuperpowerDale's superpower is her extraordinary ability to solve complex problems and persevere through challenges. In today's episode, she explained, “When I run into a problem, the first thing I have to do is tell myself, don't be afraid. You've solved other problems in the past. You can solve this one.” Dale emphasized that problems often contain valuable information that leads to solutions, encouraging others to examine challenges closely rather than avoiding them.After discovering that an FDA-approved drug had antiviral activity, Dale faced a seemingly insurmountable challenge: making the drug work effectively in people. “I thought, I will not be able to solve this problem. It's too hard,” she admitted. Yet, she persevered, combining the drug with another FDA-approved ingredient. This breakthrough created the BRG family of cancer drugs, which kill nearly all cancer cells in preclinical studies after a single dose. Her ability to persist through doubt and difficulty exemplifies her superpower.Tips for Developing Perseverance in Problem-Solving:Acknowledge Your Strengths: Remind yourself that you've solved tough problems before and can do it again.Examine Problems Closely: Instead of avoiding challenges, look for clues within the problem itself to guide solutions.Break Down the Problem: Address each component of the challenge one step at a time.Stay Focused: Resist the urge to pivot too quickly; often, solutions lie in persistence.Find Inspiration: Remember the impact your work can have on others to stay motivated.By following Dale's example and advice, you can make perseverance in problem-solving a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileDale M. Walker (she/her):Co-founder, owner, and Chief Executive Officer, The Burlington HC Research Group, Inc. (BHCRG)About The Burlington HC Research Group, Inc. (BHCRG): BHCRG is working to advance a new family of investigational drugs called BRG Therapeutics. Based on pre-clinical studies, two members of this family show potent anticancer activity across human cancer cell lines representing seven different tissues of origin, including lung cancer (four subtypes), prostate cancer (three types), triple-negative breast cancer (two types), ovarian cancer (two types), pancreatic cancer (one type), pleural mesothelioma (two types), and pre-myeloblastic leukemia (one type, tested with a single BRG drug). In tissue-culture models, BRG drugs demonstrate an unusually strong ability to eliminate nearly all cancer cells after a single dose while achieving this result at doses that are non-toxic to normal human cells. Each BRG drug delivers two active ingredients, and the primary component (ingredient #1) also inhibits the replication of viruses spanning all three major viral genome classes—DNA viruses, RNA viruses, and reverse-transcribing/retroviruses—with activity shown in vitro against influenza, COVID-19, HIV, and Ebola and other viruses. Although such breadth is uncommon and has led some observers to believe no drug could achieve these effects, the evidence shows that the human body naturally produces several essential compounds with similarly broad anticancer and antiviral functions; BRG drugs work through analogous biochemical mechanisms but produce stronger effects in controlled laboratory studies. These naturally occurring comparators include N-acetylcysteine, glutathione, and vitamin C (only at pharmacologic doses). Taken together, BRG Therapeutics represents a next-generation, multi-targeted approach designed to overcome one of the central limitations of modern oncology—drug resistance—by restoring normal cellular regulation, reactivating p53, correcting redox imbalance, and neutralizing reactive species to selectively eliminate cancer cells while preserving healthy tissue.Website: bhcrg.comCompany Facebook Page: facebook.com/profile.php?id=61584197824692Other URL: invest.fundinghope.com/offering/brg/detailsBiographical Information: My husband Vernon and I work together as a team, and we have advanced BRG therapeutics to their present state of development by collaboration. We both are veterinarians with advanced training in pathology, so that make us ‘veterinary pathologists'. Vernon also has a PhD in experimental and molecular pathology. What many people do not know is that veterinary pathologists have key roles in drug development and safety testing. Before the discovery of the BRG drugs, most of our work focused on health risks from human exposures to environmental, workplace, or medicinal agents/compounds. We were working with BRG active ingredient #1, which is FDA-approved as the active form of a cell protective drug – that means that it protects normal cells from the damaging effects of radiation and some chemicals. We were testing the ability of this agent to protect normal cells from the deleterious effects of some of the first drugs like AZT developed to treat HIV. We were surprised to learn that this cell protective drug had antiviral activity all on its own. Even though this active ingredient had been around for several decades, no one had ever reported these results before we did. We soon learned why we were the first to make this discovery - the active ingredient of this cell protective drug worked well in tissue culture as an antiviral agent, but antiviral effects were not achieved in living animals. This sent us on a long road figuring out why this was – after all, this agent worked to protect normal cells in living animals and people, so why would it not work as an antiviral agent in the same animals and people? It actually took several years to understand the nature of the problems, and even more time to figure out a solution. That solution was the BRG therapeutics.Vernon and I had little experience studying viruses, and much more experience studying cancer and anticancer drugs, and we knew that this active ingredient had anticancer activity, so we decided to start with testing a BRG drug as an anticancer agent. Our first experiment in a human, pre-myeloblastic leukemia cell line showed us anticancer effects beyond anything that we could have imagined. We were so excited, but we still had a long journey of work and discovery ahead of us. To date we have tested two BRG drugs and they kill cancer cells in all human cancer cell lines tested to date (one drug tested in 15 human cancers, the other tested in 14). A paper summarizing these results was published in 2023.LinkedIn Profile: linkedin.com/in/dale-m-walker-bhcrgPersonal Facebook Profile: facebook.com/profile.php?id=61556212335476Support Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, and SuperGreen Live. Learn more about advertising with us here.Max-Impact Members(We're grateful for every one of these community champions who make this work possible.)Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Superpowers for Good Live Pitch, December 11, 2025, at 8:00 PM Eastern / 5:00 PM Pacific, will bring together four mission-driven founders—Fran Maier (BabyQuip), Farooq Zama (CureValue), Andrei Evulet (Jetoptera), and Erin Martin (Pump For Joy)—as they present their companies live to a national audience on e360tv, YouTube, and LinkedIn. Hosted by Devin Thorpe, CEO and Founder of The Super Crowd, Inc., this special broadcast showcases entrepreneurs raising capital to solve real-world problems across family travel, healthcare access, disaster response aviation, and maternal health. Viewers are encouraged to watch the live pitches and then continue the experience by joining the Private Investor Session immediately following the broadcast, where attendees can engage directly with founders, ask deeper questions, and explore their active investment offerings in a focused, off-air environment. Whether you are an active investor or simply interested in the future of mission-driven innovation, this event offers a rare opportunity to witness purpose-driven companies in action and connect with them directly after the show.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on December 16, 2025, at 1:30 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, December 17, 2025, at 12:00 PM Eastern, will feature Devin Thorpe, CEO and Founder of The Super Crowd, Inc., leading a session on “Designing a Winning Marketing Strategy for Your Investment Offering.” Drawing on his deep experience in impact crowdfunding and investment storytelling, Devin will break down the essential elements of building a marketing strategy that attracts, engages, and converts potential investors. Participants will learn how to identify and reach the right audience, craft messages that build trust, and develop a promotional plan that supports sustained momentum throughout a raise. Whether you're preparing for your first regulated investment crowdfunding campaign or looking to strengthen an ongoing one, this SuperCrowdHour will provide the insights and practical frameworks you need to elevate your offering and boost investor participation.SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don't miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year.Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.CfPA President-elect's Vision for 2026 with Brian Belley, December 17 at 2:00 PM ET – reserve your spot now!If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

In this powerful episode of Keeping Abreast, Dr. Jenn Simmons sits down with Ryan Sternagel, founder of The Stern Method, to share the story that reshaped his life: his son's cancer diagnosis and the desperate search for answers that followed. What began as a parent's nightmare became a deep dive into integrative medicine, environmental toxicity, nutrition, and the healing power of community.Ryan opens up about navigating a rigid medical system, facing pressure from institutions, and refusing to ignore his intuition. He and Dr. Jenn explore what happens when families question conventional recommendations, how holistic therapies can support traditional treatment, and why creating a healing environment is essential.This is a conversation about resilience, advocacy, and the belief that healing requires more than protocols. It's about parents becoming empowered, finding the right team, and discovering hope in the darkest moments.In This Episode, You Will Learn:How Ryan's son's diagnosis launched his mission in integrative healthThe challenges families face when questioning conventional treatmentWhy intuition and research matter in medical decision makingHow nutrition and alternative therapies support cancer careThe emotional and practical realities of navigating the systemThe importance of community, mindset, and family supportWhy no single therapy is ever a silver bulletHow environment and lifestyle shape healingThe role of supplements within a comprehensive planWhat it means to build a truly healing home

This week on the Podcast, we are joined by Dr Amr Hanbali.During Blood Cancer Awareness Month, Guy Martin, news editor at The Pharma Letter, sat down with Dr Hanbali to discuss his experiences treating patients with CAR T-cell therapy in the Middle East.With extensive experience in hematology and the treatment of blood disorders such as leukemia and myeloma, Dr Hanbali has been closely involved in expanding access to advanced therapies across the region.Dr Hanbali discussed the evolution of blood cancer treatment in the Middle East, the unique challenges patients face in accessing cutting-edge therapies, and how CAR T-cell treatments are offering renewed hope for long-term remission.He also shared his personal reflections on the impact of this therapy on patients and families, what needs to happen to improve regional access, and his vision for the future of blood cancer care in the next decade.

Dr. Vernon Sondak explains what Mohs surgery is, and why it may be preferable in some cases.

Taken as a group, blood cancers are the fifth most common type of cancer in New Zealand - affecting around one in twenty people during their lifetime. But some patients are forced to seek help overseas because a treatment that could save them isn't available here. The Wellington based Malaghan Institute of Medical Research is working to change that. Winner of this year's Breakthrough Project category in the KiwiNet Awards, Malaghan is currently conducting phase two of its CAR-T cell therapy clinical trials. The therapy essentially uses the body's own immune system to target and kill cancer cells. Professor Robert Weinkove is the Clinical Director and he speaks to Mihi about the next major step in their push to make it a standard part of cancer care in New Zealand.

Claudin 18.2 is a novel biomarker for advanced gastric and gastroesophageal junction cancer. Patients who test positive for claudin 18.2 may be candidates for the monoclonal antibody, zolbetuximab, which directly targets this biomarker. In this episode, CANCER BUZZ speaks with Manish A. Shah, MD, FASCO, director of the Gastrointestinal Oncology Program at Weill Cornell Medicine, about how claudin 18.2 is shaping treatment decisions and some of the clinical trials pursuing more information about the potential for this biomarker. CANCER BUZZ also speaks with Sasha Watson, PharmD, outpatient medical oncology clinical pharmacist at Sylvester Comprehensive Cancer Center, about the importance of engaging the whole multidisciplinary team in biomarker testing for optimal patient outcomes.   "I often talk to my gastroenterologist and ask them to get more than 1 biopsy to make sure that we have enough tissue for now and even in the future." - Manish A. Shah, MD, FASCO Instead of lumping all gastric cancers into one group, we use these biomarkers to split them out... We have more refined and tailored treatments for patients with gastroesophageal adenocarcinoma based on these biomarkers." - Manish A. Shah, MD, FASCO "Nurses in the infusion center are a huge help that we absolutely need, and administering this treatment would be very difficult if we didn't have scaled and experienced nurses here." - Aleksandra (Sasha) Watson, PharmD "What I see is just a lot of patients having hope—some new part of their cancer that we can target with a drug that we previously didn't have any options for." - Aleksandra (Sasha) Watson, PharmD   Guests:               Manish A. Shah, MD, FASCO  Director, Gastrointestinal Oncology Program Weill Cornell Medicine New York, NY Aleksandra (Sasha) Watson, PharmD  Outpatient Medical Oncology Clinical Pharmacist (GI + Sarcoma) Sylvester Comprehensive Cancer Center Miami, FL Resources ACCC Biomarkers Webpage ACCCBuzz Blog: Importance of Biomarker Testing, Patient Goals and Education When Treating Gastric Cancer

Today's guest, Stephen Yarbrough, was diagnosed with Type 1 diabetes at the age of 70 (in 2025) after undergoing immunotherapy treatment for melanoma.In an extremely rare outcome, the treatment that helped fight his cancer also triggered an autoimmune reaction that destroyed his pancreas' ability to produce insulin. Only a fraction of patients ever experience this, yet Stephen's journey shows how Type 1 diabetes can appear in unexpected ways and at any stage of life.Over the past 10 months, Stephen has learned to navigate glucose monitoring, insulin therapy and an entirely new type of daily routine.Shortly after his diagnosis, Stephen faced the heartbreaking loss of his wife of thirty-two years following her sudden pancreatic cancer diagnosis. His willingness to speak openly about grief, resilience and the lessons he has gained along the way offers a powerful perspective that will absolutely resonate with you.Today Stephen joins us to share his path through illness, adjustment and recovering, and his appreciation for life's blessings.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

Join host Talaya Dendy on Navigating Cancer TOGETHER for another inspiring conversation with the truly remarkable Wenora Johnson.Wenora is a three-time cancer survivor (colorectal, endometrial, and basal cell carcinoma) and a passionate patient and research advocate. In this episode, she shares her incredible, decades-long journey and how her background in the Navy instilled the grit and discipline she needed to face these health challenges.What You'll Learn:Lynch Syndrome & Genetic Testing: Wenora discusses the pivotal role that genetic testing and the discovery of Lynch syndrome played in her early detection and survival. This segment is a must-listen for anyone considering testing.The Power of Policy Change: Hear about Wenora's dedicated work in patient advocacy, including her efforts to push for policy changes that would lower the recommended age for initial colonoscopies.Self-Advocacy & Resilience: Get real-world advice on how to stand up for yourself in the healthcare system and how Wenora harnessed her inner resilience to overcome multiple diagnoses.Caregiving Insights: The conversation touches on the often-overlooked challenges and realities faced by caregivers.Whether you are a patient, a caregiver, or simply looking for a story of extraordinary determination, Wenora's insights and message of hope are invaluable. Don't miss this episode!✨Episode Highlights:02:12 Meet Wenora Johnson: A Three-Time Survivor06:22 The Impact of Lynch Syndrome on Her Journey10:08 Why Genetic Testing Is So Important16:04 Fighting for Change: Advocacy and Policy33:00 Understanding Caregiving Challenges36:19 Tips for Self-Advocacy and Building Resilience43:19 Wenora's Final Thoughts and Resources (FORCE)Transcript: https://bit.ly/podscript177Resource: FORCE, https://www.facingourrisk.org/about-usInspired by Wenora's resilience? Start your journey with calm. Download your FREE Guided Meditation: "Calming Your Mind After a Cancer Diagnosis." Get inner peace now! https://www.ontheotherside.life/guidedmeditation

Have you ever thought of the role of homeopathy in the care of cancer survivors?   In this episode, Dr. Amy Rothenberg will discuss the value of natural medical approaches, including homeopathy, in addressing both acute and chronic conditions, as well as the effects of conventional cancer treatment. Additionally, she will discuss her book, "You Finished Treatment, Now What?" a guide for natural medicine and lifestyle approaches to address health issues that remain after cancer treatment and lower the risk of recurrence.    Dr. Amy Rothenberg is a doctor, teacher, writer, and advocate for healthy living who has practiced as a licensed naturopathic physician since 1986 in Northampton, Massachusetts. She is also the American Association of Naturopathic physicians 2017 physician of the year, she was the longtime medical editor for the Institute of natural medicine. And she, along with her husband, Dr. Paul Herscu, has taught through the New England School of Homeopathy since 1988. When she was diagnosed with cancer in 2014, Dr. Rothenberg sought care at a renowned teaching hospital and worked with providers with expertise in integrative natural medicine oncology to create her medical dream team. She recently released her book, You Finish Treatment, Now What? a field guide for cancer survivors. This book is a roadmap for lifestyle and natural medicine to address health challenges that persist after care and reduce the risk of recurrence. In his spare time, Dr. Rothenberg enjoys the good life in the countryside where she lives.    Check out these episode highlights: 02:31 - How was she introduced to homeopathy 08:07 - What is her book "You Finished Treatment, Now What?" all about 13:32 - How to change your internal environment to be less hospitable to cancer 20:29 - The concept of prescribing cascade and its side effects 22:52 - Empowering the patient in your clinic 25:23 - The beauty and the promise of homeopathy 30:01 - The benefits of using homeopathy for cancer 31:33 - 80% of the diagnosis of the three most lethal diseases is lifestyle preventable 33:37 - Different ways of bodily detoxification 35:39 - Conventional vs. natural medicine in cancer care 37:40 - The need for community and connections   Connect with Dr. Amy Rothenberg Website: https://dramyrothenberg.com/   If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode.   Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies   Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s   Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom

Welcome back to The Healing Pen and a Mic Companion Podcast! In the second episode, Talaya Dendy sits down with Donya Dawson, a courageous cancer survivor, proud member of the Rondo community, and dedicated public servant with the State of Minnesota.Live from the Mali Center in St. Paul, Donya shares her transformative journey of healing and empowerment following her breast cancer diagnosis. Donya discusses how her experience ignited a belief in creating spaces for connection, healing, and encouragement, a value deeply embedded in her work. Tune in to hear Donya's inspiring story, learn the benefits of journaling for emotional healing, and discover the importance of support systems and resources for those navigating their own health challenges. Her work is grounded in the belief that everyone deserves the opportunity to reach their next level of leadership, and she embodies the value of paying it forward. whether by making connections, offering help, or asking for support because true strength is built in community. Whether you're on a healing journey or supporting someone who is, this episode offers hope, inspiration, and tips on harnessing the power of words for well-being.Support Our Mission / Partner With Us:Bring Healing to Your Community: Interested in hosting The Healing Pen and a Mic workshop in your city or organization? We'd love to partner with you!Sponsor Future Workshops: Help us continue offering these much-needed, workshops to the cancer community.For partnership or sponsorship inquiries, please email us at nctpodcastfan@gmail.com.

Welcome to the Healing Pen and a Mic Companion Podcast! In this powerful introductory episode, join Talaya Dendy, a 14-year cancer thriver, cancer doula, and compassionate facilitator, as she unveils the vision behind The Healing Pen and a Mic.Discover the transformative power of combining journaling and storytelling (through podcasting) as a path to healing within the cancer community. Talaya sets the stage for her unique Journaling & Podcast Workshop, emphasizing the importance of emotional exploration, giving voice to your story, and finding authentic connection when navigating the uncertainties of a cancer journey, including survivorship post-treatment.This episode offers a glimpse into the workshop's impact, inviting you into the welcoming, supportive space at The Mali Center in St. Paul, MN. You'll gain insights into how this initiative helps foster emotional comfort, spiritual peace, and resilience, drawing inspiration from the brave voices of cancer survivors, patients, and caregivers.Support Our Mission / Partner With Us:Bring Healing to Your Community: Interested in hosting The Healing Pen and a Mic workshop in your city or organization? We'd love to partner with you!Sponsor Future Workshops: Help us continue offering these vital, free workshops to the cancer community.For partnership or sponsorship inquiries, please email us at nctpodcastfan@gmail.com.

World-renowned sexual health expert, Dr Chris Nelson, Chief of Psychology at Memorial Sloan-Kettering Cancer Centre, joins us in studio to run through the new Movember-supported "Guidelines for Sexual Health Care for Prostate Cancer Patients". A really helpful overview and structure for anyone working in this field, and for patients and their loved ones. Chris shares his 20-plus years of experience working in this field at one of the world's premier prostate cancer centres.Even better on our YouTube channel  Links:Movember Sexual Health Guidelines

In this episode of Bench to Bedside, Dr. Roy Jensen speaks with Dr. Anna Arthur and Dr. Gregory Gan about their innovative cross-disciplinary work at the intersection of nutrition and radiation oncology. They explore how their combined expertise leads to holistic cancer treatment approaches, focusing on the effects of diet, inflammation, and treatment response on patient outcomes. Both experts share their personal and professional journeys into their respective fields, the collaborative projects they have undertaken, and the way they integrate multidisciplinary insights into improving cancer care. They also highlight their efforts to mentor the next generation of researchers, underscoring the value of collaboration in scientific innovation. 00:00 Introduction to Cross-Disciplinary Collaboration 00:41 Meet the Experts: Dr. Anna Arthur and Dr. Gregory Gan 00:48 Journey into Their Respective Fields 02:02 Challenges and Realizations in Cancer Research 05:22 The Intersection of Nutrition and Radiation Oncology 10:28 Collaborative Projects and Their Impact 19:31 Mentoring the Next Generation of Researchers 23:14 Future Directions in Integrating Nutrition and Cancer Treatment 25:04 Conclusion and Final Thoughts Links from this Episode: ·       Learn more about Dr. Anna Arthur ·       Learn about Dr. Gregory Gan ·       Learn about the Nutrition Shared Resource at the cancer center ·       Learn about head and neck cancer To ensure you get our latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center.

About the Guest(s): Dr. Kristin Hieshetter is the host of the "Functional Health Radio" podcast. Dr. Kristen is an expert in holistic health practices and functional medicine, bringing years of experience in treating patients with a focus on integrative approaches. Her keen interest lies in enabling individuals to reach optimal health through informed decisions and lifestyle changes. Dr. Kristen is known for her engaging discussions on contemporary health topics, as well as her dedication to improving public health awareness internationally. Episode Summary: In this episode of "Functional Health Radio," Dr. Kristin Hieshetter delves into the intriguing topic of Ivermectin, exploring its potential use beyond its historical application as an anti-parasitic medication. Spurred by questions from her patients, Dr. Kristen investigates whether Ivermectin could be effectively repurposed for cancer treatment, a subject gaining them significant attention and research interest in recent years. She discusses how Ivermectin has a history of effectiveness in treating parasitic infections, but also reveals new and promising research that suggests its potential role in oncology. The episode highlights Dr. Kristen's detailed exploration of scientific studies on Ivermectin's effect on various cancer types, including bladder cancer, esophageal cancer, pancreatic cancer, and triple-negative breast cancer. Dr. Kristen refers to multiple research articles and findings, emphasizing Ivermectin's mechanism of action, which includes inducing oxidative stress and DNA damage in cancer cells. Throughout the discussion, she provides a compelling narrative about the potential paradigm shifts in cancer treatment and urges listeners to consider these findings, especially if they or their loved ones are affected by these conditions. Key Takeaways: Ivermectin, originally discovered as an anti-parasitic drug, is being researched for its potential use in cancer treatment, thanks to its ability to induce cancer cell death. Recent studies have shown that Ivermectin may enhance the efficacy of existing chemotherapy treatments, particularly for difficult-to-treat cancers like pancreatic and triple-negative breast cancer. Ivermectin has demonstrated the ability to selectively target and cause apoptosis in cancer cells without harming normal cells. While historical usage of Ivermectin in human treatments is well-established, ongoing research into its applications in oncology could mark a significant shift in therapeutic strategies. Despite its promising potential, listeners are cautioned about the importance of consulting medical professionals before considering any new treatments. Notable Quotes: "Ivermectin is much more than a horse dewormer; it's cheap, effective, and has been widely used for human treatment since 1987." "This study primarily looked at ivermectin, and it wasn't a combination therapy. It was just ivermectin, showing very good results against bladder cancer." "Pancreatic cancer is characterized by a really high death rate and very poor prognosis, making ivermectin's potential effects particularly exciting." "You've got this modulated electrohyperthermia, you can exploit the difference in the electromagnetic field and bioelectrical properties between cancer cells and regular tissues." "Ivermectin exerts anti-cancer effects by activating the same pathways it targets in parasites, which is an extraordinary finding." Resources: PubMed: A source of numerous articles Dr. Kristin referenced in her research on Ivermectin and its potential in cancer treatment PubMed. World Health Organization's List of Essential Medicines: Inclusion of Ivermectin as an essential anti-parasitic treatment. YouTube Channel: Dr. Kristin may reference visual media for additional context on various topics discussed in the podcast. Dr. Kristin Hieshetter shares her insights and encourages listeners to explore these discussions further with their healthcare providers. Don't miss the opportunity to hear the complete episode for an in-depth understanding of Ivermectin's potential impact on cancer therapy and more enriching health content each week on "Functional Health Radio." Stay tuned for progressive updates and responsible health discussions led by Dr. Kristin.

Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ For a list "The Top 10 Things Having Cancer Has Taught Me" please email help@ChefAJ.com Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. To book a consultation with Matt: https://form.jotform.com/241997228318164 Matthew Lederman, MD, is a board-certified Internal Medicine Physician and leading innovator in holistic health. Known for integrating plant-based nutrition, Nonviolent Communication (NVC), trauma-informed care, and lifestyle medicine, he emphasizes the deep connection between physical, emotional, and relational well-being. A certified NVC Trainer through the Center for Nonviolent Communication (CNVC), Dr. Lederman blends Polyvagal Theory, Somatic Awareness, and Pain Reprocessing to help people address root causes of chronic health issues, build emotional resilience, and strengthen meaningful connections. He co-hosts the webe Parents podcast and is the author of Wellness to Wonderful, which unites medical science, psychology, spirituality, and life wisdom to guide individuals toward lasting health and joy. He also co-founded Kinectin, an AI-driven platform for cultivating deeper, more fulfilling relationships. Dr. Lederman has co-authored six books—including the New York Times bestseller Forks Over Knives Plan—and appeared in the acclaimed documentary Forks Over Knives. He has served as Vice President of Medical Affairs at Whole Foods Market, lectured for eCornell, taught in medical schools, and co-created the webe kälm device for emotional regulation. As co-founder of Connection Docs, he integrates NVC and emotional health with practical, science-backed tools that foster resilience, balance, and meaningful relationships for individuals and families. Email (questions & requests): Support@ConnectionDocs.com Website: https://www.connectiondocs.com/ Free Resources (includes Feelings & Needs Sheet for children AND Role-Play Video “Talking to Your Child About ‘Too Much' Device Time”) : https://www.connectiondocs.com/resources Substack (Weekly Articles on Connection): https://substack.com/@connectiondocs Breath & Body Regulation Training Tool: https://webekalm.com/ webe Pärents Podcast https://webekalm.com/pages/webeparents AI Connection Coach:https://app.kinectin.com/signup Main Book WELLNESS TO WONDERFUL: 9 Pillars for Living Healthier, Longer, and with Greater Joy: https://www.amazon.com/dp/B0C2S1JGZK?ref=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&ref_=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&social_share=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&starsLeft=1&skipTwisterOG=1&bestFormat=true Children's E-Books (Supporting Children Bringing More Connection Into Their Lives): Healing Shame and Connecting to Self-Worth and Intrinsic Value: https://webekalm.com/products/lily-and-her-beautiful-flower Being Honest with Care https://webekalm.com/products/ella-and-the-two-gifts-ebook Supporting Children During Emergencies (fires, earthquakes, etc):'https://webekalm.com/products/brave-hearts-facing-the-fire-ebook Social Media: Instagram: https://www.instagram.com/TheConnectionDocs Substack Newsletter: https://connectionDocs.substack.com Facebook: https://www.facebook.com/connectionDocs X: https://x.com/connectionDocs

CAR T therapy has delivered remarkable results for people with certain blood cancers—sometimes sending aggressive disease into deep remission after a single infusion. But today, only about 20% of eligible patients can actually get it. In this episode, sponsored by our partners at Allogene Therapeutics, Katie sits down with Dr. Zachary Roberts to unpack why access remains so limited and how new allogeneic (or “off-the-shelf”) CAR T therapies could be a turning point. They discuss how using healthy donor T-cells, rather than a patient’s own, may help bypass manufacturing hurdles and bring advanced treatment to more oncologists, more hospitals, and more communities. To learn more, visit Alpha3trial.com. #AllogenePartnerSee omnystudio.com/listener for privacy information.

"Any time the patient hears the word 'cancer,' they shut down a little bit, right? They may not hear everything that the oncologist or urologist, or whoever is talking to them about their treatment options, is saying. The oncology nurse is a great person to sit down with the patient and go over the information with them at a level they can understand a little bit more. To go over all the treatment options presented by the physician, and again, make sure that we understand their goals of care," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer treatment considerations for nurses.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 21, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 373: Biomarker Testing in Prostate Cancer Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 208: How to Have Fertility Preservation Conversations With Your Patients Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Nurses Are Key to Patients Navigating Genitourinary Cancers Sexual Considerations for Patients With Cancer The Case of the Genomics-Guided Care for Prostate Cancer ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) Clinical Journal of Oncology Nursing articles: Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer Other ONS resources: Biomarker Database (refine by prostate cancer) Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Brachytherapy Huddle Card External Beam Radiation Huddle Card Hormone Therapy Huddle Card Luteinizing Hormone-Releasing Hormone Antagonist Huddle Card Sexuality Huddle Card American Cancer Society prostate cancer page National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "I think it's important to note that urologists are usually the ones that are doing the diagnosis of prostate cancer and really start that staging of prostate cancer. And the medical oncologists usually are not consulted until the patient is at a greater stage of prostate cancer. I find that it's important to state because a lot of our patients start with urologists, and by the time they've come to us, they're a lot further staged. But once a prostate cancer has been suspected, the patient needs to be staged for the extent of disease prior to that physician making any treatment recommendations. The staging includes doing a core biopsy of the prostate gland. During this core biopsy, they take multiple different cores at different areas throughout the prostate to really look to see what the cancer looks like." TS 1:46 "[For] the very low- and low-risk group, the most common [treatment] is active surveillance. ... Patients can be offered other options such as radiation therapy or surgery if they're not happy with active surveillance. ... The intermediate-risk group has favorable and unfavorable [status]. So, if they're a favorable, their Gleason score is usually a bit lower, things are not as advanced. These patients are offered active surveillance and then either radical prostatectomy with possible removal of lymph nodes or radiation—external beam or brachytherapy. If a patient has unfavorable intermediate risk, they are offered radical prostatectomy with removal of lymph nodes, external radiation therapy plus hormone therapy, or external radiation with brachytherapy. All three of these are offered to patients, although most frequently we see that our patients are taken in for radical prostatectomy. For the high- or very high-risk [group], patients are offered radiation therapy with hormone therapy, typically for one to three years. And then radical prostatectomy with removal of lymph nodes could also be offered for those patients." TS 7:55 "Radiation can play a role in any risk group depending on the patient's preference. ... The types of radiation that we use are external beam, brachytherapy, which is an internal therapy, and radiopharmaceuticals, [which are] more for advanced cancer, but we are seeing them used in prostate [cancer] as well. External beam radiation focuses on the tumor and any metastasis we may have with the tumor. It can be used in any risk [group] and for recurrence if radiation has not been done previously. If a patient has already been radiated to the pelvic area or to the prostate, radiation is usually not given again because we don't want to damage the patient any further. Brachytherapy is when we put radioactive pellets directly into the prostate. For early-stage prostate cancer, this can be given alone. And for patients who have a higher risk of the cancer growing outside the prostate, it can be given in combination with external beam radiation. It's important to note with brachytherapy, it cannot be used on patients who've had a transurethral resection of the prostate or any urinary problems. And if the patient has a large prostate, they may have to be on some hormone therapy prior to brachytherapy, just to shrink that prostate down a little bit to get the best effect. ... Radiopharmaceuticals treat the prostate-specific membrane antigen." TS 11:05 "The side effects of surgery are usually what deter the patient from wanting surgery. The first one is urinary incontinence. A lot of times, a patient has a lot of urinary incontinence after they have surgery. The other one is erectile dysfunction. A lot of patients may not want to have erectile dysfunction. Or, if having an erection is important to the patient, they may not want to have surgery to damage that. In this day and age, physicians have gotten a lot better at doing nerve-sparing surgeries. And so they really do try to do that so that the patient does not have any issues with erectile dysfunction after surgery. But [depending on] the extent of the cancer where it's growing around those nerves or there are other things going on, they may not be able to save those nerves." TS 15:26 "Luteinizing hormone-releasing hormone, or LHRH antagonists or analogs, lower the amount of testosterone made by the testicles. We're trying to stop those hormones from growing to prevent the cancer. ... When we lower the testosterone very quickly, there can be a lot more side effects. But if we lower it a little bit less, we can maybe help prevent some of them. The side effects are important. When I was writing this up, I was thinking, 'Okay, this is basically what women go through when they go through menopause.' We're decreasing the estrogen. We're now decreasing the testosterone. So, the patients can have reduced or absent sexual desire, they can have gynecomastia, hot flashes, osteopenia, anemia, decreased mental sharpness, loss of muscle mass, weight gain, and fatigue." TS 17:50 "What we all need to remember is that no patient is the same. They may not have the same goals for treatment as the physicians or the nurses want for the patient. We talked about surgery as the most common treatment modality that's presented to patients, but it's not necessarily the option that they want. It's really important for healthcare professionals to understand their biases before talking to the patients and the family. It's also important to remember that not all patients are in heterosexual relationships, so we need to explain recovery after treatment to meet the needs of our patients and their sexual relationships, which is sometimes hard for us. But remembering that—especially gay men—they may not have the same recovery period as a heterosexual male when it comes to sexual relationships. So, making sure that we have those frank conversations with our patients and really check our biases prior to going in and talking with them." TS 27:16

On Talking Royals this week, Charlene White is joined by our Royal Editor Chris Ship and Royal Expert Lizzie Robinson.They discuss the Princess of Wales's busy week at work as she continues her gradual return after cancer treatment - which involved her first speech, and a reunion with Paddington the Bear.Plus, we take a look back at some of the best Royal Variety Performance meet-and-greet moments, and the best crossovers of superstars and monarchs.And - a sneak-peak of life in Meghan and Harry's house at Christmas, as a new trailer is released for the Duchess of Sussex's festive Netflix show.

In this episode, host Shikha Jain, MD, speaks with Jason Williams, MD, and Nathan Goodyear, MD, about innovations in immunotherapy, the future of cancer care and more. •    Welcome to another exciting episode of Oncology Overdrive 1:02 •    About Williams 1:12 •    About Goodyear 1:56 •    The interview 3:08 •    Nathan, can you explain the concept of your medical philosophy, Docēre rāphè, and how you integrate it into your practice? 3:29 •    Jason, how did you get to where you are today, and how did you end up founding the Williams Cancer Institute? 5:28 •    Nathan, as an OB-GYN and lifestyle physician, what was your path to this space and at Williams Cancer Institute? 14:22 •    How do you both navigate being creative in the current climate of misinformation from a patient and physician standpoint?  20:17 •    Jason, what are the benefits and challenges of practicing in other countries versus in the United States? 26:05 •    Discussion on patient education through scientific evidence and innovation. 31:00 •    If someone could only listen to the last minute of this episode, what would you want listeners to take away? 33:37 •    How to contact Goodyear & Williams 35:42 •    Thanks for listening 36:11 Jason Williams, MD, DABR, is a medical doctor, board-certified radiologist and image-guided cancer specialist. As a leader in immunotherapy, he performed the world's first ablation procedure combined with intra-tumoral immunotherapy injections. Dr. Williams serves as the Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, which he founded to advance innovative cancer treatments. Nathan Goodyear, MD, MD(H), is an integrative medicine physician, board-certified in obstetrics and gynecology, and a leader in wellness and cancer prevention. He specializes in functional and regenerative medicine, focusing on healing and teaching the body to restore itself. Dr. Goodyear works at the Williams Cancer Institute, pioneering innovative cancer care with a holistic approach. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Goodyear and Williams can be reached at williamscancerinstitute.com. Disclosures: Jain, Goodyear and Williams report no relevant financial disclosures. 

Could the future of cancer treatment be natural, non-toxic, and even anti-aging? In this episode of The Aging Well Podcast, Dr. Jeff Armstrong welcomes Dr. Jeff Gross, founder of ReCELLebrate and a pioneer in regenerative stem cell and exosome medicine.Dr. Gross explains how activated Natural Killer (NK) cell-derived exosomes are changing the way we approach cancer treatment and immune health—offering a powerful, non-toxic alternative to chemotherapy and radiation. He reveals how these therapies boost the body's natural defense systems, eliminate cancer and “zombie” cells that accelerate aging, and help restore vitality without harming healthy tissue.We'll explore what makes NK cell exosome therapy unique, how it might serve as both treatment and prevention, and its potential role in the future of anti-aging medicine.Whether you're interested in cancer care, longevity science, or breakthroughs in immunotherapy, this conversation could change the way you think about health, healing, and aging well.Learn more at https://recellebrate.com/Please, support The Aging Well Podcast by hitting the ‘like' button, subscribing/following the podcast, sharing with a friend, and….BUY the products you need to… age well from our trusted affiliates and support the mission of The Aging Well Podcast*.The Aging Well Podcast merchandise | Show how you are aging well | Use the promo code AGING WELL for free shipping on orders over $75 | https://theagingwellpodcast-shop.fourthwall.com/promo/AGINGWELLAuro Wellness | Glutaryl—Antioxidant spray that delivers high doses of glutathione (“Master Antioxidant”) | 10% off Code: AGINGWELL at https://aurowellness.com/agingwellpodcastBerkeley Life | Optimize nitric oxide levels | Purchase your starter kit at a 15% discount | Use the promo code: AGINGWELL15 | https://berkeleylife.pxf.io/c/6475525/3226696/31118Oxford Healthspan | Primeadine®, a plant-derived spermidine supplement | 10% off code: AGINGWELL | https://oxford-healthspan.myshopify.com/AgingWellProlon | The Fasting Mimicking Diet (FMD) is a revolutionary five-day nutrition program scientifically formulated to mimic the effects of a prolonged water fast while still allowing nourishment - supporting the benefits of fasting without the challenges and risks that come from water-only fasts. | For the best available discount always use this link: https://prolonlife.com/theagingwellpodcastL-Nutra Health | The medical division of L-Nutra, focused on helping people manage and potentially reverse chronic health conditions, like type 2 diabetes, prediabetes, insulin resistance, and obesity, using personalized, lifestyle-based programs grounded in evidence, not prescriptions. | Use this link: https://l-nutrahealth.com/theagingwellpodcastThrive25—Your personal longevity advisor | https://www.thrive25.com/early-access?via=william-jeffreyFusionary Formulas | Combining Ayurvedic wisdom with Western science for optimal health support. | 15% off Code: AGINGWELL | https://fusionaryformulas.com/Jigsaw Health | Trusted supplements. “It's fun to feel good.” | Click the following link for 10% off: https://www.jigsawhealth.com/?rfsn=8710089.1dddcf3&utm_source=refersion&utm_medium=affiliate&utm_campaign=8710089.1dddcf3Dr Lewis Nutrition | Fight neurodegeneration and cognitive decline with Daily Brain Care by Dr Lewis Nutrition—a proven daily formula designed to protect and restore brain function. | 10% off code: AGINGWELL or use the link: https://drlewisnutrition.com/AGINGWELLTruDiagnostic—Your source for epigenetic testing | 12% off Code: AGEWELL or use the link: https://shop.trudiagnostic.com/discount/AGEWELL*We receive commission on these purchases. Thank you.

BUFFALO, NY – November 18, 2025 – A new #review was #published in Oncotarget (Volume 16) on November 14, 2025, titled “Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota.” This review, led by first author Hoang Do and correspondent author Ashakumary Lakshmikuttyamma from Thomas Jefferson University, explores how bifidobacterium, a common probiotic found in the gut, may contribute to cancer prevention and therapy. By analyzing existing studies, the authors highlight the growing importance of gut health in cancer treatment and shed light on how bifidobacterium could complement standard cancer therapies. Bifidobacterium is widely known for promoting digestive health and is often included in fermented foods and dietary supplements. However, emerging evidence suggests it may also play a broader role in immune regulation and cancer defense. The review explains how certain strains of bifidobacterium may enhance the effectiveness of chemotherapy, radiation, and immunotherapy in cancers such as breast, lung, colorectal, and gastric cancers. According to the review, bifidobacterium influences cancer outcomes through several biological mechanisms. It helps regulate immune function by reducing inflammation and supporting the activity of immune cells that target tumors. For instance, strains like B. longum and B. breve have been shown to lower levels of harmful inflammatory markers and boost anti-inflammatory responses. These changes can make cancer treatments more effective while also reducing side effects. “Presence of Bifidobacterium breve in gut microbiota extended the median progression-free survival of NSCLC patients.” The review also discusses how bifidobacterium helps detoxify the body by breaking down cancer-causing compounds and limiting their ability to damage cells. In preclinical studies, the probiotic reduced the activity of enzymes that produce carcinogens and helped in converting food-based substances into cancer-fighting agents. Some strains were even found to suppress genes that promote tumor growth and increase molecules that trigger cancer cell death. The authors emphasize that diet plays a critical role in supporting the growth of bifidobacterium. Foods rich in dietary fiber, especially those containing inulin and oligosaccharides like garlic, onions, or leeks, can help increase its levels in the gut. This suggests that simple dietary changes could not only improve gut health but also support cancer prevention and treatment strategies. Although the review presents compelling evidence, the authors stress the need for more clinical trials to determine how different strains of bifidobacterium affect specific types of cancer. Personalized approaches may be necessary to match the right probiotic strains with individual treatment plans. As research continues to uncover the link between gut microbes and cancer, bifidobacterium stands out as a promising natural ally that could enhance the body's defenses and improve cancer treatment outcomes. DOI - https://doi.org/10.18632/oncotarget.28779 Correspondence to - Ashakumary Lakshmikuttyamma - axl025@jefferson.edu Abstract video - https://www.youtube.com/watch?v=KTWJDAN15lY Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28779 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Biochemist Lingyin Li survived breast cancer at just 30 and now works to harness the human immune system to fight cancers that have long evaded treatment. T cells, she says, are powerful cancer killers, but they can be oblivious. She and her lab colleagues have discovered a masking enzyme that squelches the immune system's “danger signals” and are now developing drugs to block that enzyme. She likens her work to an arms race between cancer and immunotherapy. “The cancers are not getting smarter, but we are,” Li tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Lingyin LiConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Lingyin Li, a professor of biochemistry at Stanford University.(00:03:38) Research MotivationLingyin explains how her breast cancer diagnosis inspired her research.(00:04:31) How T-Cells WorkT-cell mechanisms and why they struggle to reach solid tumors.(00:05:38) Immune System OverviewInnate and adaptive immunity and how mutations make cancer recognizable.(00:07:28) Awakening the Immune SystemEfforts to stimulate innate immune cells to detect and expose tumors.(00:10:54) The Cancer SignalDiscovery of cancer-derived DNA signals that alert the immune system.(00:13:01) Cancer's Evasion MechanismHow tumors destroy immune signals to hide from detection.(00:14:26) ENPP1 EnzymeIdentification of ENPP1 as the enzyme enabling immune evasion.(00:15:22) Balancing Immunity and SafetyRole of ENPP1 in autoimmunity and the challenge of targeting it safely.(00:19:30) ENPP1 InhibitorsDevelopment of molecules to block ENPP1 and enhance immune signaling.(00:24:55) Preclinical FindingsThe promising results against aggressive solid tumors in animal studies(00:28:05) From Lab to ClinicThe progress toward FDA approval and preparation for human testing.(00:31:04) Future In a MinuteRapid-fire Q&A: innovation, collaboration, and the outlook for cancer treatment.(00:33:14) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A breakthrough that could reshape cancer treatment.GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body's own natural killer cells to identify and destroy cancer. In this interview, Executive Chairman & CEO Michael Breen discusses the company's latest clinical progress and the potential of its lead drug candidate, GTB-3650.He also shares insights into the science behind TriKE®, the company's pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIYAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

A breakthrough that could reshape cancer treatment.GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body's own natural killer cells to identify and destroy cancer. In this interview, Executive Chairman & CEO Michael Breen discusses the company's latest clinical progress and the potential of its lead drug candidate, GTB-3650.He also shares insights into the science behind TriKE®, the company's pipeline for solid tumors and autoimmune diseases, and its mission to develop more humane cancer therapies that bring real hope to patients worldwide.Learn more about GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/jduKYNKHMIYAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia

"What am I holding onto so tightly that I would never change?"  Our guest last week (and the week before!), Becca, once declared she'd never undergo treatment again—until her cancer returned and she found herself asking how they'd treat it. We often know exactly what we're going to do in difficult situations...until we don't. This week, Cody reflects on psychological flexibility and the profound courage it takes to change your mind. Why we hold so tightly to old stances, the hubris of declaring what we'd do in someone else's situation, and the strength required to grow and evolve. Join Cody for this brief but powerful exploration of identity, humility, and the grace of changing course. --- For more information on the sponsor of this episode, please visit the Iliff Death Care Collective.

Fasting and intermittent fasting have been in the news in recent months. In this episode, Faiza Kalam, PhD, MD, director of the James Food, Activity Sleep and Time (FACT) Lab explains the basics and how fasting and intermittent fasting can lead to improved cholesterol, LDL and blood pressure levels and rates and help people lose weight without the use of weight-reducing drugs that can have side effects. Fasting can also help cancer patients during their treatment. “The initial research has shown there is less fatigue and better quality of life for cancer patients during chemotherapy treatment who fast,” said Kalam.

Martha Sklavos is the founder and CEO of Aloe Therapeutics, she’s working on a treatment option for “advanced solid tumors.” “Forty percent of Americans will be diagnosed with cancer at some point in their lifetime, so it will touch us all in one way, shape or form,” Sklavos said.  

Deb Krier on Leading During Cancer Treatment (The Price and Value Journey, Episode 152) When the leader is in treatment, the business still needs direction. On this episode of The Price and Value Journey, host John Ray welcomes Deb Krier, entrepreneur, cancer advocate, host of The Business Power Hour, and founder of TryingNotToDie.LIVE. Drawing on more […]

Over the last five years, billions of people have received at least one dose of a COVID-19 mRNA vaccine. New research has found an unanticipated result of these vaccines: Cancer treatments are more effective for some vaccinated patients, and many live longer than their unvaccinated counterparts. This news comes at a time where the federal government is slashing funding for mRNA research. Host Ira Flatow speaks to lead study author Adam Grippin and vaccine expert Eric Topol.Guests: Dr. Adam Grippin is a radiation oncologist at the MC Anderson Cancer Center in Houston, Texas. Dr. Eric Topol is a cardiologist and genomics professor at the Scripps Research Institute in La Jolla, California.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this deeply inspiring episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Pete Sulack—chiropractor, functional medicine practitioner, and founder of Unhealthy Anonymous—for a powerful conversation about defying the odds after a terminal cancer diagnosis.Dr. Sulack shares how he turned a death sentence into a journey of hope, healing, and renewal. Through faith, nutrition, and lifestyle transformation, he reclaimed his health and now guides others to do the same. Together, he and Dr. Jenn challenge conventional cancer paradigms, exploring how mindset, personalized nutrition, and spiritual alignment can unlock the body's innate capacity to heal.This episode invites listeners to rethink what's possible in cancer recovery and beyond. It's a story of courage, resilience, and faith in both science and spirit—reminding us that health is not something we outsource but something we build from within.In This Episode, You Will Learn:How Dr. Sulack overcame a terminal brain cancer diagnosisWhy functional medicine focuses on healing the whole person, not just treating diseaseThe crucial role of personalized nutrition in recoveryHow food sensitivities and gut health shape overall wellnessWhy conventional medicine often overlooks the importance of dietThe link between faith, mindset, and the body's innate ability to healHow to take proactive responsibility for your healthWhy empowerment and education can change the cancer care paradigm

Send us a textCould exercise be just what the doctor ordered for recovery during chemotherapy? In this episode of “The UMB Pulse,” explore this novel approach to cancer recovery with Ian Kleckner, PhD, MPH, associate professor at the University of Maryland School of Nursing and director of the SYNAPSE Center. Kleckner shares how exercise can alleviate symptoms of chemotherapy-induced peripheral neuropathy and improve the quality of life for cancer survivors. Through his research, Kleckner investigates how movement can reduce inflammation, enhance brain and body coordination, and empower patients to reclaim their lives. Chapter Markers 00:00 – Introduction 00:00:17 – Cancer Treatment & Neuropathy 00:01:37 – Guest Introduction: Dr. Ian Kleckner 00:05:06 – Understanding Neuropathy 00:09:38 – Research Findings: Brain & Exercise 00:13:33 – Exercise Intervention & Clinical Trials 00:19:08 – Practical Advice & Takeaways 00:23:31 – Conclusion & CreditsListen to The UMB Pulse on Apple, Spotify, Amazon Music, and wherever you like to listen. The UMB Pulse is also now on YouTube.Visit our website at umaryland.edu/pulse or email us at umbpulse@umaryland.edu.

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000 women who are newly diagnosed with advanced ovarian cancer every year, about 20,000 in the US, and the frontline standard of care hasn't seen a change in the treatment in about 25 years. So this is for newly diagnosed women. The very first treatment that they would have, which we call frontline treatment, is a platinum-based chemotherapy. So carboplatin and Paclitaxel are both administered through IV over an hour for carboplatin, about three hours for Paclitaxel. So most women go directly to chemotherapy and then surgery, and then chemotherapy. Some women will go straight to surgery and then have this chemotherapy afterwards."   "Our approach is a DNA-based immunotherapy candidate that we have in Phase 3. We refer to the lead candidate as IMNN-001, and this is a non-viral nanoparticle that is administered directly into the cavity of interest. So, what we call the micro-tumor environment is the peritoneal cavity, where the cancer actually resides, and it's delivered through a catheter. And it basically has a very powerful anti-cancer fighting cytokine, IL-12, that is encoded in this immunotherapy. And it causes the cells that are within each woman's body, both cancer and non-cancer alike, to start producing activities that will help fight these complex cancer cells that exist."  #IMUNON #OvarianCancer #DNABasedImmunotherapy #WomensHealth #CancerAwareness  imunon.com Download the transcript here

Dr. Stacy Lindborg, President and CEO of IMUNON, has developed a DNA-based immunotherapy candidate for the treatment of ovarian cancer. This therapy works by administering the drug, which utilizes IL-12, a powerful anti-cancer cytokine, directly into the cavity where the cancer resides, thereby affecting the tumor microenvironment. Trials are showing that the drug can produce significant life extension when used in combination with standard chemotherapy. Stacy explains, "There are about 300,000 women who are newly diagnosed with advanced ovarian cancer every year, about 20,000 in the US, and the frontline standard of care hasn't seen a change in the treatment in about 25 years. So this is for newly diagnosed women. The very first treatment that they would have, which we call frontline treatment, is a platinum-based chemotherapy. So carboplatin and Paclitaxel are both administered through IV over an hour for carboplatin, about three hours for Paclitaxel. So most women go directly to chemotherapy and then surgery, and then chemotherapy. Some women will go straight to surgery and then have this chemotherapy afterwards."   "Our approach is a DNA-based immunotherapy candidate that we have in Phase 3. We refer to the lead candidate as IMNN-001, and this is a non-viral nanoparticle that is administered directly into the cavity of interest. So, what we call the micro-tumor environment is the peritoneal cavity, where the cancer actually resides, and it's delivered through a catheter. And it basically has a very powerful anti-cancer fighting cytokine, IL-12, that is encoded in this immunotherapy. And it causes the cells that are within each woman's body, both cancer and non-cancer alike, to start producing activities that will help fight these complex cancer cells that exist."  #IMUNON #OvarianCancer #DNABasedImmunotherapy #WomensHealth #CancerAwareness  imunon.com Listen to the podcast here

Today's guest is Lashelle Scott, breast cancer survivor, advocate, and policy administrator. She champions awareness, equity, and legislation, serving as an ambassador for the Susan G. Komen Cener for Public Policy and the American Cancer Society.We talk about healthcare and the financial burdens placed on so many, policy changes that are worth fighting for, the importance of funding for research, and so much more.No matter what side of the political aisle you align with, the truth is that cancer treatments are expensive and something needs to change. Conversations like this are an important step, along with the work Lashelle and so many others are doing. Resources:Lashelle's Facebook: https://www.facebook.com/thefutureSenatorScottLashelle's Instagram: https://www.instagram.com/senatornorthstar2021/Lashelle's Email: the.hope.project.initiative@gmail.comFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Jim Foote, CEO and Founder of First Ascent Biomedical a pioneer in functional precision medicine (FPM) that aims to eliminate guesswork from cancer treatment. After losing his son to cancer, Jim left a career in cybersecurity to build a data-driven platform that combines AI, robotics and real-time tumour testing to help doctors choose the right therapy for each patient. In this episode, we explore how FPM differs from traditional genomics-only testing, why tumours can respond differently even with the same patient and how AI can support rather than replace clinicians in treatment decisions. Jim also shares the economic impact of ineffective therapies, the challenges of scaling regulatory innovation in oncology, and why the future of cancer care depends on personalisation at the  cellular level.Timestamps:[00:00:45] What Is Functional Precision Medicine?[00:02:00] Jim's Personal Journey from Tech to Healthcare[00:05:50] Overcoming Regulatory and Systemic Gatekeepers[00:08:13] From Reactive Care to Personalised Treatment[00:09:08] What Lab Findings Reveal about Cancer Cells[00:10:30] Why Genomics Alone Isn't Enough[00:12:03] AI as Decision Support Not a Decision Maker[00:15:55] Cancer in Younger Populations and Misconceptions[00:20:25] Reducing Cost and Waste in Cancer Treatment[00:26:34] What Success Really Means to Jim FooteConnect with Jim - https://www.linkedin.com/in/jim-foote/ Learn more about First Ascent Biomedical - https://www.linkedin.com/company/firstascentbio/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwalSubscribe to the Podcast

Welcome back to Navigating Cancer TOGETHER! We're picking up right where we left off with the remarkable Peta-Ann Wood, a breast cancer thriver and Soulful Coach.Part 1, "Choosing Flat: Peta-Ann's Journey to Self-Acceptance," was about the courage to choose (flatness, self-advocacy, and leaving people-pleasing behind). Now, Part 2 is the roadmap for flourishing once those massive decisions are made.Peta-Ann opens up about the powerful shift from managing her life to becoming a Happiness Coach. She reveals how her personal journey, touching on her late AuDHD diagnosis and her life-affirming choice to go flat, gave her a unique lens for helping others find inner peace and contentment.If you are struggling with the transition after treatment ends, or if you feel like your self-worth took a hit during your diagnosis, this episode is dedicated to you. Peta-Ann shares candid advice and heartwarming success stories that prove recovery isn't just about survival, it's about building a happier life than you had before.✨Episode Highlights:03:36 Understanding the shift: Why Peta-Ann focused on Happiness Coaching.08:47 How Lived Experience fuels her personal growth and guidance.16:28 Navigating Cancer TOGETHER: A reflection on building genuine community support.26:49 Words of Encouragement: Direct, honest advice for the cancer community.Transcript: https://bit.ly/podscript175Part I: https://podcast.ausha.co/navigatingcancertogether/choosing-flat-peta-ann-s-journey-to-self-acceptanceConnect & Engage with Peta-Ann:Website: https://www.elegantrebelponders.comInstagram: https://www.instagram.com/elegant.rebel.pondersFacebook: https://www.facebook.com/ElegantRebel44Call to Action & Community:If Peta-Ann's adventure resonated with you, or you know someone else needs to hear this transformative conversation, please share this episode! Text the link to a fellow survivor, patient, or caregiver who could use a dose of guidance and hope today.Don't miss the next human-centered conversation! Subscribe or follow Navigating Cancer TOGETHER on your favorite podcast app or platform to ensure you get immediate alerts for every new episode.Join the Waitlist: Get ready to connect with a supportive community! Join the waitlist for our Navigating Cancer TOGETHER forum here: https://www.ontheotherside.life/forum-waitlistHosted, Produced, Written, and Edited by: Talaya DendyDisclaimer: The information on this podcast is for general informational purposes only and SHOULD NOT be used as a substitute for sound professional medical advice, evaluation, or care from your physician or other qualified health care provider.Hosted by Ausha. See ausha.co/privacy-policy for more information.

Here I explain the lymphatic system, a crucial bodily network for overall health and appearance. I explain how the lymphatic system works to remove cellular waste and fluid from your organs and combat infections. I provide science-based tools that support your lymphatic system for the sake of health and appearance, including: how to reduce fluid retention in your limbs, trunk or face, how to eliminate 'bags' under your eyes and brain fog, and how to improve cardiac health and longevity. Because your lymphatic system lacks a central pump, it needs the mechanical forces generated by specific types of bodily movement, breathing and pressure to circulate your lymph properly, and I explain how you can activate these. I also explain how to support optimal functioning of your glymphatic system, a brain- and spinal cord waste-clearing system active during sleep that is crucial for brain functioning and longevity, including to prevent dementia. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman LMNT: https://drinklmnt.com/huberman David: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Lymphatic System (00:04:11) Circulatory System, Heart; Oxygen, Nutrient & Waste Transfer (00:11:03) Lymphatic System, Fluid, Lymphedema, Chronic Inflammation; Brain Fog (00:14:52) Sponsor: LMNT & David Protein (00:17:28) Lymphatic Vessels, Tool: Enhance Lymphatic Drainage with Movement (00:26:24) Tools: Jumping (Rebounding), Treading Water, Swimming (00:27:41) Tool: Swelling, Lymphatic Drainage & Diaphragmatic Breathing (00:32:05) Swimming & Lymphatic Flow; Tai Chi (00:34:00) Lymphatic Massage, Cancer & Lymphedema; Jade Roller & Gua Sha (00:37:28) Sponsor: AGZ by AG1 (00:38:56) Lymph Flow, Tool: Lymphatic Massage & Manual Lymphatic Drainage (00:45:02) Immune Function of Lymphatic System, Sore Lymph Nodes (00:54:24) Cancer Treatment, Lymph Nodes & Lymphedema (00:57:02) Limb Swelling, Minor Lymphedema & Inflammation, Lymphatic Boots (01:00:09) Sponsors: Eight Sleep (01:01:43) Glymphatic System, Brain & Sleep (01:05:56) Sleep & Brain Waste Recycling; Discovery of the Glymphatic System (01:12:24) Enhance Glymphatic Clearance, Brain Fog, Age, Tool: Side Sleeping Position (01:15:54) Tools: Optimize Sleep, Cardiovascular Exercise, Elevate Feet, Pillow (01:17:29) Puffy Face, Tool: Lymphatic & Facial Massage (01:21:23) Sponsor: Function (01:23:11) Tool: Hydration & Lymphatic Support (01:24:48) Tool: Cardiovascular Exercise & Lymphatic Vessels, Heart, Aging (01:31:06) Tool: Infrared & Red Light, Mitochondria, Lymphedema, Skin Appearance (01:36:08) Key Takeaways (01:37:21) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Immune 100 live at the Incubator SARS-CoV-2 mRNA vaccines sensitize tumors to checkpoint immunotherapy (Nature) People with some cancers live longer after mRNA vaccines (Nature) Immune checkpoint inhibitors (NCI) Broad immunity from influenza H5 vaccine (Nature) Derek Smith on antigenic cartography (TWiV 99 at 2:53) Letters read on TWiV 1265 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Kathy – Permethrin-treated baby wraps for malaria prevention and Phil Sharp and the Biotech Revolution Rich – Lydia Fairchild; Tetragametic Chimerism (NEJM) Alan – Warning Signs Vincent – radio.garden thanks to Kim! Listener Pick Jamie – SkyCards by Flightradar24 Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

When someone finishes a cancer treatment, it can feel like the end of the story. For many, it may just be the beginning–risk of recurrence looms, long-term medications (and their side effects) begin, and it’s hard to get your bearings. What do you really need to know?In this candid conversation, Katie sits down with Dr. Lillian Smyth, Senior Vice President and Global Development Head for Breast Cancer at Eli Lilly and Company, and LaShae Rolle, a breast cancer survivor, public health researcher, and powerlifter. Together, they explore what life after breast cancer treatment really looks like: from follow-up care and managing side effects to navigating fears about recurrence and finding strength in advocacy.This episode—created in partnership with Eli Lilly—is about more than medicine. It’s about empowerment: knowing your “normal,” asking the right questions, and embracing life following cancer treatment.See omnystudio.com/listener for privacy information.